PGIM Quant Solutions Mid-Cap Value Fund (PMVQX) is an open-end mutual fund that seeks long-term capital growth by investing at least 80% of its investable assets in equity and equity-related securities of mid-cap companies considered undervalued by the market; it employs a quantitative, value-oriented investment approach focusing on stocks with potential for growth through diversification into mid-sized firms across sectors such as industrials, financials, information technology, and healthcare. The fund offers multiple share classes including A (SPRAX), C, R, R2, R4, R6 (PMVQX), and Z, with net expense ratios ranging from 0.73% for R6 to 1.95% for C as of February 2026; it maintains a portfolio with an average weighted market capitalization of approximately $22.3 billion, a P/E ratio of 15.2, and a 12-month turnover ratio of 97%, featuring top holdings like Western Digital Corp, Bank of New York Mellon Corp, Exelon Corp, and Allstate Corp. PGIM Quantitative Solutions, the fund's adviser and a division of PGIM (the global investment management business of Prudential Financial, Inc.), is headquartered in Newark, New Jersey, with operations extending across the United States; founded in 1975, it specializes in systematic quantitative strategies for institutional and individual investors targeting mid-cap value exposure. In recent developments, the fund has implemented adjustments to its quantitative investment process to address long-run performance challenges and enhance index-relative consistency, as noted by Morningstar; PGIM Quantitative Solutions' parent PGIM entered a strategic partnership with Partners Group in September 2025 to deliver multi-asset portfolio solutions combining public and private markets expertise, alongside merging its public and private credit arms into a $1 trillion unified platform in June 2025. The fund operates primarily in U.S. markets, serving retirement plans, individual investors, and institutions seeking mid-cap value opportunities with sector allocations overweight in information technology and healthcare relative to benchmarks.